JSPR — Jasper Therapeutics Share News
0.000.00%
Last trade - 00:00Jasper Therapeutics tumbles after unveiling equity offering plans
Brief: Jasper Therapeutics Announces Proposed Public Offering Of Common Stock
Health Rounds: Experimental Jasper drug helps stem cell transplant patients avoid toxic chemotherapy in tiny trial
Jasper Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Inc expected to post a loss of $1.33 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth
Jasper Therapeutics falls after halting clinical programs
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
U.S. STOCKS ON THE MOVE-U.S. Bancorp, IonQ, BlackRock
Jasper hits record low as co halts asthma trial due to drug lot issue
U.S. STOCKS ON THE MOVE- Cogent Biosciences, Sandstorm Gold, Tesla
Jasper Therapeutics plunges as co halts asthma trial due to drug lot issue
Jasper Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Jasper Therapeutics Inc expected to post a loss of $1.31 a share - Earnings Preview
Brief: Jasper Therapeutics Inc Files For Common Stock Offering Of Up To $100 Million - SEC Filing
Brief: Jasper Therapeutics terminates Cantor sales agreement
Brief: Jasper Therapeutics files for mixed shelf offering of up to $300 mln
Jasper Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary